 Based on patients LDL-C level, at visit 1 ScreeningBaseline patient will receive prescription of initial or increased dose of statin 10-80 mgday andor ezetimibe 10 mgday for the following 6 weeks. At visit 2 6 weeks FU patients will receive prescription of statin dose increased andor ezetimibe 10 mg per day for the following 6 weeks based on their target level of LDL-C. At visit 3 week 12 -18 FU for patients who did not reach their LDL-C target, ezetimibe 10 mg per day will be considered if appropriate for the patient for the following 14 weeks to complete the observational study. 